Series B - Ginkgo Bioworks

Series B - Ginkgo Bioworks

Investment Firm

Overview

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Announced Date

Jul 23, 2015

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Viking Global Investors

Viking Global Investors

Viking Global Investors is a early_stage_venture and late_stage_venture firm.

Participant Investors

11

Investor Name
Participant InvestorMassVentures
Participant InvestorFelicis
Participant InvestorDCVC
Participant InvestorY Combinator
Participant InvestorKen Arnold

Round Details and Background

Ginkgo Bioworks raised $53328100 on 2015-07-23 in Series B

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Company Funding History

18

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 10, 2024
Grant - Ginkgo Bioworks
1-undefined
Jun 08, 2016
Series C - Ginkgo Bioworks
6-100.0M
Jul 23, 2015
Series B - Ginkgo Bioworks
11-53.3M
Jul 16, 2014
Seed Round - Ginkgo Bioworks
14-1.0M

Recent Activity

There is no recent news or activity for this profile.